nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP2D6—Lomustine—brain cancer	0.169	0.218	CbGbCtD
Cinacalcet—CYP1A2—Carmustine—brain cancer	0.167	0.216	CbGbCtD
Cinacalcet—CYP2D6—Hydroxyurea—brain cancer	0.128	0.166	CbGbCtD
Cinacalcet—CYP3A4—Temozolomide—brain cancer	0.126	0.163	CbGbCtD
Cinacalcet—CYP3A4—Lomustine—brain cancer	0.107	0.139	CbGbCtD
Cinacalcet—CYP1A2—Etoposide—brain cancer	0.0496	0.0641	CbGbCtD
Cinacalcet—CYP3A4—Etoposide—brain cancer	0.026	0.0336	CbGbCtD
Cinacalcet—Metastatic neoplasm—Procarbazine—brain cancer	0.0163	0.0964	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Hydroxyurea—brain cancer	0.0126	0.0746	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Temozolomide—brain cancer	0.00987	0.0583	CcSEcCtD
Cinacalcet—Thrombosis—Procarbazine—brain cancer	0.00442	0.0261	CcSEcCtD
Cinacalcet—Neoplasm malignant—Procarbazine—brain cancer	0.00367	0.0216	CcSEcCtD
Cinacalcet—Dexfenfluramine—CYP2C9—brain cancer	0.00284	0.656	CrCbGaD
Cinacalcet—Thrombosis—Carmustine—brain cancer	0.00277	0.0163	CcSEcCtD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—CTNNB1—brain cancer	0.00264	0.0501	CbGpPWpGaD
Cinacalcet—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00242	0.046	CbGpPWpGaD
Cinacalcet—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00222	0.0421	CbGpPWpGaD
Cinacalcet—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00221	0.0418	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—EGFR—brain cancer	0.00209	0.0397	CbGpPWpGaD
Cinacalcet—Infection—Carboplatin—brain cancer	0.002	0.0118	CcSEcCtD
Cinacalcet—Infection—Lomustine—brain cancer	0.00175	0.0103	CcSEcCtD
Cinacalcet—Anorexia—Lomustine—brain cancer	0.00168	0.0099	CcSEcCtD
Cinacalcet—Body temperature increased—Carboplatin—brain cancer	0.00159	0.00939	CcSEcCtD
Cinacalcet—Decreased appetite—Lomustine—brain cancer	0.00153	0.00903	CcSEcCtD
Cinacalcet—Fluoxetine—CYP2C9—brain cancer	0.00149	0.344	CrCbGaD
Cinacalcet—CASR—GPCR ligand binding—PTCH2—brain cancer	0.00144	0.0274	CbGpPWpGaD
Cinacalcet—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00142	0.0084	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—TRPC6—brain cancer	0.00142	0.027	CbGpPWpGaD
Cinacalcet—Arrhythmia—Procarbazine—brain cancer	0.0014	0.00829	CcSEcCtD
Cinacalcet—Body temperature increased—Lomustine—brain cancer	0.00139	0.00821	CcSEcCtD
Cinacalcet—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00137	0.0261	CbGpPWpGaD
Cinacalcet—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00132	0.0251	CbGpPWpGaD
Cinacalcet—Dehydration—Temozolomide—brain cancer	0.00128	0.00754	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.00127	0.0241	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—OR14C36—brain cancer	0.00127	0.024	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—OR4C12—brain cancer	0.00127	0.024	CbGpPWpGaD
Cinacalcet—Anaemia—Procarbazine—brain cancer	0.00126	0.00747	CcSEcCtD
Cinacalcet—Cough—Procarbazine—brain cancer	0.00119	0.00705	CcSEcCtD
Cinacalcet—Convulsion—Procarbazine—brain cancer	0.00119	0.007	CcSEcCtD
Cinacalcet—Hypertension—Procarbazine—brain cancer	0.00118	0.00698	CcSEcCtD
Cinacalcet—Myalgia—Procarbazine—brain cancer	0.00117	0.00688	CcSEcCtD
Cinacalcet—Arthralgia—Procarbazine—brain cancer	0.00117	0.00688	CcSEcCtD
Cinacalcet—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00116	0.0221	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—OR4C12—brain cancer	0.00115	0.0218	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—OR14C36—brain cancer	0.00115	0.0218	CbGpPWpGaD
Cinacalcet—Cardiac failure—Etoposide—brain cancer	0.00113	0.00665	CcSEcCtD
Cinacalcet—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00112	0.0212	CbGpPWpGaD
Cinacalcet—Vomiting—Lomustine—brain cancer	0.00112	0.0066	CcSEcCtD
Cinacalcet—Infection—Procarbazine—brain cancer	0.00111	0.00655	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Temozolomide—brain cancer	0.0011	0.00652	CcSEcCtD
Cinacalcet—Depression—Carmustine—brain cancer	0.00109	0.00645	CcSEcCtD
Cinacalcet—Anorexia—Procarbazine—brain cancer	0.00106	0.00629	CcSEcCtD
Cinacalcet—Depression—Temozolomide—brain cancer	0.00106	0.00623	CcSEcCtD
Cinacalcet—Nausea—Lomustine—brain cancer	0.00104	0.00617	CcSEcCtD
Cinacalcet—Hypotension—Procarbazine—brain cancer	0.00104	0.00616	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00102	0.00601	CcSEcCtD
Cinacalcet—Paraesthesia—Procarbazine—brain cancer	0.001	0.00592	CcSEcCtD
Cinacalcet—Cramp muscle—Etoposide—brain cancer	0.00099	0.00585	CcSEcCtD
Cinacalcet—Anaemia—Hydroxyurea—brain cancer	0.000979	0.00578	CcSEcCtD
Cinacalcet—Decreased appetite—Procarbazine—brain cancer	0.000971	0.00573	CcSEcCtD
Cinacalcet—Oedema peripheral—Carmustine—brain cancer	0.000969	0.00572	CcSEcCtD
Cinacalcet—Fatigue—Procarbazine—brain cancer	0.000963	0.00569	CcSEcCtD
Cinacalcet—Constipation—Procarbazine—brain cancer	0.000955	0.00564	CcSEcCtD
Cinacalcet—Oedema peripheral—Temozolomide—brain cancer	0.000936	0.00553	CcSEcCtD
Cinacalcet—Convulsion—Hydroxyurea—brain cancer	0.000918	0.00542	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Procarbazine—brain cancer	0.000913	0.00539	CcSEcCtD
Cinacalcet—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000899	0.017	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000895	0.00529	CcSEcCtD
Cinacalcet—Urticaria—Procarbazine—brain cancer	0.000887	0.00524	CcSEcCtD
Cinacalcet—Body temperature increased—Procarbazine—brain cancer	0.000883	0.00521	CcSEcCtD
Cinacalcet—Abdominal pain—Procarbazine—brain cancer	0.000883	0.00521	CcSEcCtD
Cinacalcet—Arrhythmia—Carmustine—brain cancer	0.000879	0.00519	CcSEcCtD
Cinacalcet—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000864	0.0164	CbGpPWpGaD
Cinacalcet—Infection—Hydroxyurea—brain cancer	0.000859	0.00507	CcSEcCtD
Cinacalcet—Immune system disorder—Temozolomide—brain cancer	0.000858	0.00507	CcSEcCtD
Cinacalcet—Malnutrition—Carmustine—brain cancer	0.000856	0.00506	CcSEcCtD
Cinacalcet—Nervous system disorder—Hydroxyurea—brain cancer	0.000848	0.00501	CcSEcCtD
Cinacalcet—Skin disorder—Hydroxyurea—brain cancer	0.00084	0.00496	CcSEcCtD
Cinacalcet—Malnutrition—Temozolomide—brain cancer	0.000827	0.00489	CcSEcCtD
Cinacalcet—Anorexia—Hydroxyurea—brain cancer	0.000824	0.00487	CcSEcCtD
Cinacalcet—Hypersensitivity—Procarbazine—brain cancer	0.000823	0.00486	CcSEcCtD
Cinacalcet—Asthenia—Procarbazine—brain cancer	0.000801	0.00473	CcSEcCtD
Cinacalcet—Anaemia—Carmustine—brain cancer	0.000791	0.00467	CcSEcCtD
Cinacalcet—Pruritus—Procarbazine—brain cancer	0.00079	0.00467	CcSEcCtD
Cinacalcet—Dyspnoea—Hydroxyurea—brain cancer	0.000771	0.00455	CcSEcCtD
Cinacalcet—Anaemia—Temozolomide—brain cancer	0.000765	0.00452	CcSEcCtD
Cinacalcet—Diarrhoea—Procarbazine—brain cancer	0.000764	0.00451	CcSEcCtD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000762	0.0144	CbGpPWpGaD
Cinacalcet—Dyspepsia—Hydroxyurea—brain cancer	0.000761	0.00449	CcSEcCtD
Cinacalcet—Angioedema—Temozolomide—brain cancer	0.000756	0.00446	CcSEcCtD
Cinacalcet—Decreased appetite—Hydroxyurea—brain cancer	0.000751	0.00444	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000746	0.00441	CcSEcCtD
Cinacalcet—Fatigue—Hydroxyurea—brain cancer	0.000745	0.0044	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—SHH—brain cancer	0.000744	0.0141	CbGpPWpGaD
Cinacalcet—Convulsion—Carmustine—brain cancer	0.000742	0.00438	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PTCH2—brain cancer	0.000741	0.014	CbGpPWpGaD
Cinacalcet—Hypertension—Carmustine—brain cancer	0.000739	0.00436	CcSEcCtD
Cinacalcet—Constipation—Hydroxyurea—brain cancer	0.000739	0.00436	CcSEcCtD
Cinacalcet—Dizziness—Procarbazine—brain cancer	0.000739	0.00436	CcSEcCtD
Cinacalcet—Myalgia—Carmustine—brain cancer	0.000729	0.0043	CcSEcCtD
Cinacalcet—Chest pain—Carmustine—brain cancer	0.000729	0.0043	CcSEcCtD
Cinacalcet—Cough—Temozolomide—brain cancer	0.000722	0.00426	CcSEcCtD
Cinacalcet—Convulsion—Temozolomide—brain cancer	0.000717	0.00423	CcSEcCtD
Cinacalcet—Hypertension—Temozolomide—brain cancer	0.000714	0.00422	CcSEcCtD
Cinacalcet—Vomiting—Procarbazine—brain cancer	0.00071	0.00419	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—PTCH1—brain cancer	0.000705	0.0134	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SMO—brain cancer	0.000705	0.0134	CbGpPWpGaD
Cinacalcet—Myalgia—Temozolomide—brain cancer	0.000704	0.00416	CcSEcCtD
Cinacalcet—Arthralgia—Temozolomide—brain cancer	0.000704	0.00416	CcSEcCtD
Cinacalcet—Rash—Procarbazine—brain cancer	0.000704	0.00416	CcSEcCtD
Cinacalcet—Dermatitis—Procarbazine—brain cancer	0.000704	0.00415	CcSEcCtD
Cinacalcet—Headache—Procarbazine—brain cancer	0.0007	0.00413	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.0007	0.00413	CcSEcCtD
Cinacalcet—Infection—Carmustine—brain cancer	0.000694	0.0041	CcSEcCtD
Cinacalcet—Immune system disorder—Etoposide—brain cancer	0.000687	0.00406	CcSEcCtD
Cinacalcet—Body temperature increased—Hydroxyurea—brain cancer	0.000683	0.00403	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—OR14C36—brain cancer	0.000679	0.0129	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—OR4C12—brain cancer	0.000679	0.0129	CbGpPWpGaD
Cinacalcet—Infection—Temozolomide—brain cancer	0.000671	0.00396	CcSEcCtD
Cinacalcet—Anorexia—Carmustine—brain cancer	0.000666	0.00393	CcSEcCtD
Cinacalcet—Nausea—Procarbazine—brain cancer	0.000663	0.00392	CcSEcCtD
Cinacalcet—Nervous system disorder—Temozolomide—brain cancer	0.000662	0.00391	CcSEcCtD
Cinacalcet—Skin disorder—Temozolomide—brain cancer	0.000656	0.00387	CcSEcCtD
Cinacalcet—Hypotension—Carmustine—brain cancer	0.000653	0.00386	CcSEcCtD
Cinacalcet—Anorexia—Temozolomide—brain cancer	0.000644	0.0038	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—ABR—brain cancer	0.00064	0.0121	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Hydroxyurea—brain cancer	0.000637	0.00376	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Carmustine—brain cancer	0.000637	0.00376	CcSEcCtD
Cinacalcet—Muscle spasms—Etoposide—brain cancer	0.000637	0.00376	CcSEcCtD
Cinacalcet—Paraesthesia—Carmustine—brain cancer	0.000627	0.00371	CcSEcCtD
Cinacalcet—Dyspnoea—Carmustine—brain cancer	0.000623	0.00368	CcSEcCtD
Cinacalcet—Asthenia—Hydroxyurea—brain cancer	0.00062	0.00366	CcSEcCtD
Cinacalcet—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000617	0.0117	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000615	0.00363	CcSEcCtD
Cinacalcet—Anaemia—Etoposide—brain cancer	0.000612	0.00361	CcSEcCtD
Cinacalcet—Decreased appetite—Carmustine—brain cancer	0.000607	0.00359	CcSEcCtD
Cinacalcet—Paraesthesia—Temozolomide—brain cancer	0.000606	0.00358	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Carmustine—brain cancer	0.000603	0.00356	CcSEcCtD
Cinacalcet—Dyspnoea—Temozolomide—brain cancer	0.000602	0.00355	CcSEcCtD
Cinacalcet—Constipation—Carmustine—brain cancer	0.000598	0.00353	CcSEcCtD
Cinacalcet—Dyspepsia—Temozolomide—brain cancer	0.000594	0.00351	CcSEcCtD
Cinacalcet—Diarrhoea—Hydroxyurea—brain cancer	0.000591	0.00349	CcSEcCtD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000588	0.0111	CbGpPWpGaD
Cinacalcet—Decreased appetite—Temozolomide—brain cancer	0.000587	0.00347	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Temozolomide—brain cancer	0.000583	0.00344	CcSEcCtD
Cinacalcet—Fatigue—Temozolomide—brain cancer	0.000582	0.00344	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—ABR—brain cancer	0.000581	0.011	CbGpPWpGaD
Cinacalcet—Cough—Etoposide—brain cancer	0.000578	0.00341	CcSEcCtD
Cinacalcet—Constipation—Temozolomide—brain cancer	0.000577	0.00341	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—DTX2—brain cancer	0.000577	0.011	CbGpPWpGaD
Cinacalcet—Convulsion—Etoposide—brain cancer	0.000574	0.00339	CcSEcCtD
Cinacalcet—Hypertension—Etoposide—brain cancer	0.000572	0.00338	CcSEcCtD
Cinacalcet—Dizziness—Hydroxyurea—brain cancer	0.000572	0.00338	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Carmustine—brain cancer	0.000571	0.00337	CcSEcCtD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000571	0.0108	CbGpPWpGaD
Cinacalcet—Chest pain—Etoposide—brain cancer	0.000564	0.00333	CcSEcCtD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000563	0.0107	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00056	0.00331	CcSEcCtD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000559	0.0106	CbGpPWpGaD
Cinacalcet—Abdominal pain—Carmustine—brain cancer	0.000552	0.00326	CcSEcCtD
Cinacalcet—Body temperature increased—Carmustine—brain cancer	0.000552	0.00326	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Temozolomide—brain cancer	0.000552	0.00326	CcSEcCtD
Cinacalcet—Vomiting—Hydroxyurea—brain cancer	0.00055	0.00325	CcSEcCtD
Cinacalcet—Rash—Hydroxyurea—brain cancer	0.000545	0.00322	CcSEcCtD
Cinacalcet—Dermatitis—Hydroxyurea—brain cancer	0.000544	0.00322	CcSEcCtD
Cinacalcet—Headache—Hydroxyurea—brain cancer	0.000541	0.0032	CcSEcCtD
Cinacalcet—Infection—Etoposide—brain cancer	0.000537	0.00317	CcSEcCtD
Cinacalcet—Urticaria—Temozolomide—brain cancer	0.000536	0.00317	CcSEcCtD
Cinacalcet—Abdominal pain—Temozolomide—brain cancer	0.000534	0.00315	CcSEcCtD
Cinacalcet—Body temperature increased—Temozolomide—brain cancer	0.000534	0.00315	CcSEcCtD
Cinacalcet—Skin disorder—Etoposide—brain cancer	0.000525	0.0031	CcSEcCtD
Cinacalcet—Anorexia—Etoposide—brain cancer	0.000515	0.00304	CcSEcCtD
Cinacalcet—Hypersensitivity—Carmustine—brain cancer	0.000515	0.00304	CcSEcCtD
Cinacalcet—Nausea—Hydroxyurea—brain cancer	0.000513	0.00303	CcSEcCtD
Cinacalcet—Hypotension—Etoposide—brain cancer	0.000505	0.00298	CcSEcCtD
Cinacalcet—Asthenia—Carmustine—brain cancer	0.000501	0.00296	CcSEcCtD
Cinacalcet—Hypersensitivity—Temozolomide—brain cancer	0.000498	0.00294	CcSEcCtD
Cinacalcet—Paraesthesia—Etoposide—brain cancer	0.000485	0.00287	CcSEcCtD
Cinacalcet—Asthenia—Temozolomide—brain cancer	0.000484	0.00286	CcSEcCtD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000484	0.00917	CbGpPWpGaD
Cinacalcet—Dyspnoea—Etoposide—brain cancer	0.000482	0.00284	CcSEcCtD
Cinacalcet—Diarrhoea—Carmustine—brain cancer	0.000478	0.00282	CcSEcCtD
Cinacalcet—Pruritus—Temozolomide—brain cancer	0.000478	0.00282	CcSEcCtD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000477	0.00905	CbGpPWpGaD
Cinacalcet—Decreased appetite—Etoposide—brain cancer	0.00047	0.00277	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Etoposide—brain cancer	0.000466	0.00275	CcSEcCtD
Cinacalcet—Fatigue—Etoposide—brain cancer	0.000466	0.00275	CcSEcCtD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000463	0.00878	CbGpPWpGaD
Cinacalcet—Dizziness—Carmustine—brain cancer	0.000462	0.00273	CcSEcCtD
Cinacalcet—Constipation—Etoposide—brain cancer	0.000462	0.00273	CcSEcCtD
Cinacalcet—Diarrhoea—Temozolomide—brain cancer	0.000462	0.00273	CcSEcCtD
Cinacalcet—Dizziness—Temozolomide—brain cancer	0.000447	0.00264	CcSEcCtD
Cinacalcet—Vomiting—Carmustine—brain cancer	0.000444	0.00262	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Etoposide—brain cancer	0.000442	0.00261	CcSEcCtD
Cinacalcet—Rash—Carmustine—brain cancer	0.000441	0.0026	CcSEcCtD
Cinacalcet—Dermatitis—Carmustine—brain cancer	0.00044	0.0026	CcSEcCtD
Cinacalcet—Headache—Carmustine—brain cancer	0.000438	0.00258	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PTCH2—brain cancer	0.000438	0.0083	CbGpPWpGaD
Cinacalcet—Vomiting—Temozolomide—brain cancer	0.000429	0.00254	CcSEcCtD
Cinacalcet—Urticaria—Etoposide—brain cancer	0.000429	0.00253	CcSEcCtD
Cinacalcet—Abdominal pain—Etoposide—brain cancer	0.000427	0.00252	CcSEcCtD
Cinacalcet—Body temperature increased—Etoposide—brain cancer	0.000427	0.00252	CcSEcCtD
Cinacalcet—Rash—Temozolomide—brain cancer	0.000426	0.00251	CcSEcCtD
Cinacalcet—Dermatitis—Temozolomide—brain cancer	0.000425	0.00251	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HES5—brain cancer	0.000424	0.00804	CbGpPWpGaD
Cinacalcet—Headache—Temozolomide—brain cancer	0.000423	0.0025	CcSEcCtD
Cinacalcet—Nausea—Carmustine—brain cancer	0.000415	0.00245	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—STRADA—brain cancer	0.000411	0.0078	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—TRPC6—brain cancer	0.000405	0.00768	CbGpPWpGaD
Cinacalcet—Nausea—Temozolomide—brain cancer	0.000401	0.00237	CcSEcCtD
Cinacalcet—Hypersensitivity—Etoposide—brain cancer	0.000398	0.00235	CcSEcCtD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000392	0.00743	CbGpPWpGaD
Cinacalcet—Asthenia—Etoposide—brain cancer	0.000388	0.00229	CcSEcCtD
Cinacalcet—Pruritus—Etoposide—brain cancer	0.000382	0.00226	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—SHH—brain cancer	0.000382	0.00724	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000373	0.00708	CbGpPWpGaD
Cinacalcet—Diarrhoea—Etoposide—brain cancer	0.00037	0.00218	CcSEcCtD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000368	0.00698	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—TRPC6—brain cancer	0.000368	0.00698	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—SMO—brain cancer	0.000362	0.00686	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PTCH1—brain cancer	0.000362	0.00686	CbGpPWpGaD
Cinacalcet—Dizziness—Etoposide—brain cancer	0.000357	0.00211	CcSEcCtD
Cinacalcet—Vomiting—Etoposide—brain cancer	0.000344	0.00203	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—ABR—brain cancer	0.000343	0.00651	CbGpPWpGaD
Cinacalcet—Rash—Etoposide—brain cancer	0.000341	0.00201	CcSEcCtD
Cinacalcet—Dermatitis—Etoposide—brain cancer	0.00034	0.00201	CcSEcCtD
Cinacalcet—Headache—Etoposide—brain cancer	0.000339	0.002	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—GLI2—brain cancer	0.000332	0.00629	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000326	0.00617	CbGpPWpGaD
Cinacalcet—Nausea—Etoposide—brain cancer	0.000321	0.0019	CcSEcCtD
Cinacalcet—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000317	0.00601	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GLI1—brain cancer	0.000312	0.00591	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—VAV1—brain cancer	0.000304	0.00576	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000303	0.00574	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SUFU—brain cancer	0.000296	0.00561	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GFAP—brain cancer	0.000285	0.00541	CbGpPWpGaD
Cinacalcet—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000281	0.00533	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—VAV1—brain cancer	0.000276	0.00523	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HEY1—brain cancer	0.00027	0.00513	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—DLL1—brain cancer	0.000265	0.00503	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000258	0.00489	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000246	0.00466	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000242	0.0046	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SHH—brain cancer	0.000225	0.00428	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TRPC6—brain cancer	0.000217	0.00412	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000215	0.00407	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTCH1—brain cancer	0.000214	0.00405	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SMO—brain cancer	0.000214	0.00405	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000208	0.00395	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000205	0.00389	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CG—brain cancer	0.000193	0.00366	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CG—brain cancer	0.000175	0.00332	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NOTCH2—brain cancer	0.000171	0.00324	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VAV1—brain cancer	0.000163	0.00309	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000161	0.00305	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000158	0.00301	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HES1—brain cancer	0.00014	0.00266	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2—brain cancer	0.000136	0.00257	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PDGFRA—brain cancer	0.000133	0.00253	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SPP1—brain cancer	0.000129	0.00246	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000124	0.00235	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2—brain cancer	0.000123	0.00234	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IRS2—brain cancer	0.000117	0.00222	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000112	0.00212	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—APC—brain cancer	0.000103	0.00196	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CG—brain cancer	0.000103	0.00196	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	9.48e-05	0.0018	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EGFR—brain cancer	9.42e-05	0.00179	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	8.73e-05	0.00165	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	8.53e-05	0.00162	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	8.53e-05	0.00162	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RELA—brain cancer	8.08e-05	0.00153	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ERBB2—brain cancer	8.03e-05	0.00152	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8e-05	0.00152	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—brain cancer	7.28e-05	0.00138	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—brain cancer	7.09e-05	0.00135	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CTNNB1—brain cancer	7.02e-05	0.00133	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—brain cancer	6.18e-05	0.00117	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT3—brain cancer	6.12e-05	0.00116	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.85e-05	0.00111	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—brain cancer	5.69e-05	0.00108	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGFR—brain cancer	5.57e-05	0.00106	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—brain cancer	4.67e-05	0.000886	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP2C9—brain cancer	4.2e-05	0.000797	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—BSG—brain cancer	3.57e-05	0.000678	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP2C9—brain cancer	3.56e-05	0.000675	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—IDH1—brain cancer	3.07e-05	0.000583	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—BSG—brain cancer	3.03e-05	0.000574	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP2C9—brain cancer	2.75e-05	0.000521	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—IDH1—brain cancer	2.6e-05	0.000494	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ENO2—brain cancer	2.43e-05	0.000461	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—BSG—brain cancer	2.34e-05	0.000443	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.12e-05	0.000402	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ENO2—brain cancer	2.06e-05	0.00039	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—IDH1—brain cancer	2.01e-05	0.000381	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ENO2—brain cancer	1.59e-05	0.000301	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CG—brain cancer	1.11e-05	0.000211	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CG—brain cancer	9.44e-06	0.000179	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CG—brain cancer	7.29e-06	0.000138	CbGpPWpGaD
